Want tender expert help? See our tender preparation service
Tenders

Anti-cancer and immunomodulatory agents (Pärnu Hospital)

Open
In brief

Sihtasutus Pärnu Haigla is procuring antineoplastic and immunomodulating agents for Pärnu Hospital in Estonia. The estimated value is 3,307,497 EUR. This procurement is divided into lots. The deadline for submission is 19 November 2026. Notice, tender documents, and submission instructions are available on the riigihanked.riik.ee portal.

Updated October 16, 2026

Deadline
34 days left
November 19, 2026
Contract Details
Category
Supplies
Reference
316508
Value
€3,307,497
Location
Estonia
Published
October 15, 2026
CPV Code
Project Timeline

Tender Published

October 15, 2026

Deadline for Questions

November 12, 2026

Submission Deadline

November 19, 2026

Tender Opening

November 19, 2026

Win ProbabilityPRO
🔒
Upgrade to Professional
See your estimated win probability based on historical data.
Upgrade to Professional →
Buyer IntelligencePRO
🔒
Unlock Buyer Intelligence
See spending patterns, preferred procedures, and more.
Upgrade to Professional →
Sector InsightsPRO
🔒
Unlock Sector Insights
See average winning prices, competition levels, and market trends.
Upgrade to Professional →

Key facts

Estimated value
€3,307,497
Deadline
34 days left
CPV Code
33600000-6 — Pharmaceutical products
Procedure
Restricted procedure
Lots
Divided into lots
Budget
€3,307,497
Duration
Not specified
Location
Estonia
Type
Supplies
Market Benchmark
Avg. Winning Price
€92,792
Avg. Bids
2.2
Competition
Low
SME Winners
86%
3,220 tenders analyzed

Original Tender Description

Riigihanke eesmärgiks on sõlmida raamlepingud, mille objektiks on SA-le Pärnu Haigla kasvajavastaste ja immunomoduleerivate ainete ostmine, mille tehniline kirjeldus ja eeldatavad kogused on esitatud HD lisas 1.
Electronic Submission

Run Risk Analysis

Identify potential risks, inconsistencies, and red flags across all tender documents. Get a detailed risk report with severity levels and mitigation recommendations.

Login

Win Strategy

Get an AI-powered winning strategy tailored to this tender. Includes win probability score, key opportunities and challenges, recommended bid focus areas, competitive positioning insights, and actionable recommendations to maximize your chances.

Login

Competitors

Upgrade to see which companies are likely to bid on this tender, based on historical procurement data.

Login

Requirements & Qualifications

AI extracts and organizes all requirements from tender documents — mandatory qualifications, technical specifications, financial conditions, and submission rules — clearly categorized so you know exactly what's needed to bid.

Login

Basic Requirements

  • Company registration in EU required
  • Proven track record in similar projects
  • Financial stability documentation

Documents

8 documents available with AI summaries

VastavustingimusedPDF
316508_vastavustingimused.pdf -- 176.9 KB

No summary available for this document.

HD lisa 1 Tehniline kirjeldus ja hinnapakkumuse vormXLS
316508 HD lisa 1 Tehniline kirjeldus ja hinna... -- 26.1 KB

No summary available for this document.

HD lisa 3 vorm I - AvaldusDOC
316508 HD lisa 3 vorm I - Avaldus.docx -- 91.3 KB

No summary available for this document.

Hindamiskriteeriumid ja hinnatavad näitajadPDF
316508_hindamiskriteeriumid.pdf -- 50.0 KB

No summary available for this document.

Hankepass täiendatavate selgitustegaPDF
316508_hankepass_taiendavate_selgitustega.pdf -- 51.4 KB

No summary available for this document.

Hankedokument (HD)PDF
316508 HD Kasvajavastased ja immunomoduleeriv... -- 212.8 KB

No summary available for this document.

HD lisa 2 Raamlepingu projektPDF
316508 HD lisa 2 Raamlepingu projekt.pdf -- 228.1 KB

No summary available for this document.

HD lisa 3 PakkumusvormidDOC
316508 HD lisa 3 Pakkumusvormid.docx -- 95.5 KB

No summary available for this document.

Documents Preview

Sign up to view document summaries and analysis

Quality Score

Comprehensive quality analysis of this tender scoring legal compliance, clarity, completeness, fairness, practicality, data consistency, and sustainability on a 0-100 scale with detailed breakdown and recommendations.

Login